Listed

Roivant Sciences Ltd.

ROIVNasdaqCIK 1635088HealthcareFiscal year ends Mar 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$1.4m, Q1 FY2026
Operating income−$366.0m, Q1 FY2026
Net income−$189.8m, Q1 FY2026
Roivant Sciences Ltd., income statement, quarterly
Line itemUnitQ2 FY20232023-09-30Q3 FY20232023-12-31Q4 FY20232024-03-31Q1 FY20242024-06-30Q2 FY20242024-09-30Q3 FY20242024-12-31Q4 FY20242025-03-31Q1 FY20252025-06-30Q2 FY20252025-09-30Q3 FY20252025-12-31Q4 FY20252026-03-31Q1 FY20262026-06-30
Revenue$m3.6Revenue, Q2 FY2023, three months to 2023-09-30$3.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-12, accession 0001140361-24-046019.Report this figure15.6Revenue, Q3 FY2023, three months to 2023-12-31$15.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-02-10, accession 0001140361-25-003661.Report this figure9.0Revenue, Q4 FY2023, three months to 2024-03-31$9.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-05-20, accession 0001635088-26-000061. Derived: 12-month figure less the 9-month figure.Report this figure8.0Revenue, Q1 FY2024, three months to 2024-06-30$8.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-11, accession 0001140361-25-030001.Report this figure4.5Revenue, Q2 FY2024, three months to 2024-09-30$4.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-10, accession 0001635088-25-000016.Report this figure9.0Revenue, Q3 FY2024, three months to 2024-12-31$9.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-06, accession 0001635088-26-000011.Report this figure7.6Revenue, Q4 FY2024, three months to 2025-03-31$7.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-05-20, accession 0001635088-26-000061. Derived: 12-month figure less the 9-month figure.Report this figure2.2Revenue, Q1 FY2025, three months to 2025-06-30$2.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001635088-26-000090.Report this figure1.6Revenue, Q2 FY2025, three months to 2025-09-30$1.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-10, accession 0001635088-25-000016.Report this figure2.0Revenue, Q3 FY2025, three months to 2025-12-31$2.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-06, accession 0001635088-26-000011.Report this figure2.5Revenue, Q4 FY2025, three months to 2026-03-31$2.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-05-20, accession 0001635088-26-000061. Derived: 12-month figure less the 9-month figure.Report this figure1.4Revenue, Q1 FY2026, three months to 2026-06-30$1.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001635088-26-000090.Report this figure
Research and development$m115Research and development, Q2 FY2023, three months to 2023-09-30$114.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-12, accession 0001140361-24-046019.Report this figure108Research and development, Q3 FY2023, three months to 2023-12-31$108.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-02-10, accession 0001140361-25-003661.Report this figure108Research and development, Q4 FY2023, three months to 2024-03-31$107.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-05-20, accession 0001635088-26-000061. Derived: 12-month figure less the 9-month figure.Report this figure121Research and development, Q1 FY2024, three months to 2024-06-30$120.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-11, accession 0001140361-25-030001.Report this figure143Research and development, Q2 FY2024, three months to 2024-09-30$143.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-10, accession 0001635088-25-000016.Report this figure142Research and development, Q3 FY2024, three months to 2024-12-31$141.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-02-06, accession 0001635088-26-000011.Report this figure145Research and development, Q4 FY2024, three months to 2025-03-31$145.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-05-20, accession 0001635088-26-000061. Derived: 12-month figure less the 9-month figure.Report this figure153Research and development, Q1 FY2025, three months to 2025-06-30$152.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001635088-26-000090.Report this figure165Research and development, Q2 FY2025, three months to 2025-09-30$164.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-10, accession 0001635088-25-000016.Report this figure165Research and development, Q3 FY2025, three months to 2025-12-31$165.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-02-06, accession 0001635088-26-000011.Report this figure199Research and development, Q4 FY2025, three months to 2026-03-31$198.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-05-20, accession 0001635088-26-000061. Derived: 12-month figure less the 9-month figure.Report this figure202Research and development, Q1 FY2026, three months to 2026-06-30$202.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001635088-26-000090.Report this figure
Selling, general and administrative$m164Selling, general and administrative, Q2 FY2023, three months to 2023-09-30$164.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2023-11-13, accession 0001140361-23-052721.Report this figure197Selling, general and administrative, Q3 FY2023, three months to 2023-12-31$197.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-02-13, accession 0001140361-24-007260.Report this figure170Selling, general and administrative, Q4 FY2023, three months to 2024-03-31$169.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2024-05-30, accession 0001140361-24-028145. Derived: 12-month figure less the 9-month figure.Report this figure149Selling, general and administrative, Q1 FY2024, three months to 2024-06-30$148.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-08-09, accession 0001140361-24-036642.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Operating income$m(214)Operating income, Q2 FY2023, three months to 2023-09-30−$213.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-12, accession 0001140361-24-046019.Report this figure5,127Operating income, Q3 FY2023, three months to 2023-12-31$5.13bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-02-10, accession 0001140361-25-003661.Report this figure(207)Operating income, Q4 FY2023, three months to 2024-03-31−$206.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-05-20, accession 0001635088-26-000061. Derived: 12-month figure less the 9-month figure.Report this figure(102)Operating income, Q1 FY2024, three months to 2024-06-30−$102.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-11, accession 0001140361-25-030001.Report this figure(342)Operating income, Q2 FY2024, three months to 2024-09-30−$341.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-10, accession 0001635088-25-000016.Report this figure(274)Operating income, Q3 FY2024, three months to 2024-12-31−$274.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-02-06, accession 0001635088-26-000011.Report this figure(285)Operating income, Q4 FY2024, three months to 2025-03-31−$285.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-05-20, accession 0001635088-26-000061. Derived: 12-month figure less the 9-month figure.Report this figure(285)Operating income, Q1 FY2025, three months to 2025-06-30−$284.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001635088-26-000090.Report this figure(306)Operating income, Q2 FY2025, three months to 2025-09-30−$306.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-10, accession 0001635088-25-000016.Report this figure(339)Operating income, Q3 FY2025, three months to 2025-12-31−$339.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-02-06, accession 0001635088-26-000011.Report this figure415Operating income, Q4 FY2025, three months to 2026-03-31$415.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-05-20, accession 0001635088-26-000061. Derived: 12-month figure less the 9-month figure.Report this figure(366)Operating income, Q1 FY2026, three months to 2026-06-30−$366.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001635088-26-000090.Report this figure
Interest expense$m9.2Interest expense, Q2 FY2023, three months to 2023-09-30$9.2m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-13, accession 0001140361-23-052721.Report this figure9.4Interest expense, Q3 FY2023, three months to 2023-12-31$9.4m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-02-13, accession 0001140361-24-007260.Report this figure7.2Interest expense, Q4 FY2023, three months to 2024-03-31$7.2m. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-05-30, accession 0001140361-24-028145. Derived: 12-month figure less the 9-month figure.Report this figure13.4Interest expense, Q1 FY2024, three months to 2024-06-30$13.4m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-08-09, accession 0001140361-24-036642.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Income tax$m3.2Income tax, Q2 FY2023, three months to 2023-09-30$3.2m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-12, accession 0001140361-24-046019.Report this figure22.4Income tax, Q3 FY2023, three months to 2023-12-31$22.4m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-02-10, accession 0001140361-25-003661.Report this figure(5.8)Income tax, Q4 FY2023, three months to 2024-03-31−$5.8m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-05-20, accession 0001635088-26-000061. Derived: 12-month figure less the 9-month figure.Report this figure12.0Income tax, Q1 FY2024, three months to 2024-06-30$12.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-11, accession 0001140361-25-030001.Report this figure12.5Income tax, Q2 FY2024, three months to 2024-09-30$12.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-10, accession 0001635088-25-000016.Report this figure(25.6)Income tax, Q3 FY2024, three months to 2024-12-31−$25.6m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-02-06, accession 0001635088-26-000011.Report this figure49.3Income tax, Q4 FY2024, three months to 2025-03-31$49.3m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-05-20, accession 0001635088-26-000061. Derived: 12-month figure less the 9-month figure.Report this figure4.6Income tax, Q1 FY2025, three months to 2025-06-30$4.6m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001635088-26-000090.Report this figure7.0Income tax, Q2 FY2025, three months to 2025-09-30$7.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-10, accession 0001635088-25-000016.Report this figure23.3Income tax, Q3 FY2025, three months to 2025-12-31$23.3m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-02-06, accession 0001635088-26-000011.Report this figure98.4Income tax, Q4 FY2025, three months to 2026-03-31$98.4m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-05-20, accession 0001635088-26-000061. Derived: 12-month figure less the 9-month figure.Report this figure(4.0)Income tax, Q1 FY2026, three months to 2026-06-30−$4.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001635088-26-000090.Report this figure
Net income$m(304)Net income, Q2 FY2023, three months to 2023-09-30−$304.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-12, accession 0001140361-24-046019.Report this figure5,096Net income, Q3 FY2023, three months to 2023-12-31$5.10bn. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-02-10, accession 0001140361-25-003661.Report this figure(151)Net income, Q4 FY2023, three months to 2024-03-31−$151.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-05-20, accession 0001635088-26-000061. Derived: 12-month figure less the 9-month figure.Report this figure95.3Net income, Q1 FY2024, three months to 2024-06-30$95.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-11, accession 0001140361-25-030001.Report this figure(230)Net income, Q2 FY2024, three months to 2024-09-30−$230.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001635088-25-000016.Report this figure169Net income, Q3 FY2024, three months to 2024-12-31$169.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-02-06, accession 0001635088-26-000011.Report this figure(206)Net income, Q4 FY2024, three months to 2025-03-31−$206.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-05-20, accession 0001635088-26-000061. Derived: 12-month figure less the 9-month figure.Report this figure(223)Net income, Q1 FY2025, three months to 2025-06-30−$223.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001635088-26-000090.Report this figure(114)Net income, Q2 FY2025, three months to 2025-09-30−$113.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001635088-25-000016.Report this figure(266)Net income, Q3 FY2025, three months to 2025-12-31−$265.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-02-06, accession 0001635088-26-000011.Report this figure303Net income, Q4 FY2025, three months to 2026-03-31$303.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-05-20, accession 0001635088-26-000061. Derived: 12-month figure less the 9-month figure.Report this figure(190)Net income, Q1 FY2026, three months to 2026-06-30−$189.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001635088-26-000090.Report this figure
Diluted EPS$ per share(0.40)Diluted EPS, Q2 FY2023, three months to 2023-09-30−$0.40 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-12, accession 0001140361-24-046019.Report this figure6.03Diluted EPS, Q3 FY2023, three months to 2023-12-31$6.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-02-10, accession 0001140361-25-003661.Report this figurenot reported0.12Diluted EPS, Q1 FY2024, three months to 2024-06-30$0.12 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-11, accession 0001140361-25-030001.Report this figure(0.31)Diluted EPS, Q2 FY2024, three months to 2024-09-30−$0.31 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-10, accession 0001635088-25-000016.Report this figure0.23Diluted EPS, Q3 FY2024, three months to 2024-12-31$0.23 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-02-06, accession 0001635088-26-000011.Report this figurenot reported(0.33)Diluted EPS, Q1 FY2025, three months to 2025-06-30−$0.33 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001635088-26-000090.Report this figure(0.17)Diluted EPS, Q2 FY2025, three months to 2025-09-30−$0.17 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-10, accession 0001635088-25-000016.Report this figure(0.38)Diluted EPS, Q3 FY2025, three months to 2025-12-31−$0.38 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-02-06, accession 0001635088-26-000011.Report this figurenot reported(0.26)Diluted EPS, Q1 FY2026, three months to 2026-06-30−$0.26 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001635088-26-000090.Report this figure
Basic EPS$ per share(0.40)Basic EPS, Q2 FY2023, three months to 2023-09-30−$0.40 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-12, accession 0001140361-24-046019.Report this figure6.37Basic EPS, Q3 FY2023, three months to 2023-12-31$6.37 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-02-10, accession 0001140361-25-003661.Report this figurenot reported0.13Basic EPS, Q1 FY2024, three months to 2024-06-30$0.13 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-11, accession 0001140361-25-030001.Report this figure(0.31)Basic EPS, Q2 FY2024, three months to 2024-09-30−$0.31 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-10, accession 0001635088-25-000016.Report this figure0.23Basic EPS, Q3 FY2024, three months to 2024-12-31$0.23 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-02-06, accession 0001635088-26-000011.Report this figurenot reported(0.33)Basic EPS, Q1 FY2025, three months to 2025-06-30−$0.33 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001635088-26-000090.Report this figure(0.17)Basic EPS, Q2 FY2025, three months to 2025-09-30−$0.17 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-10, accession 0001635088-25-000016.Report this figure(0.38)Basic EPS, Q3 FY2025, three months to 2025-12-31−$0.38 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-02-06, accession 0001635088-26-000011.Report this figurenot reported(0.26)Basic EPS, Q1 FY2026, three months to 2026-06-30−$0.26 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001635088-26-000090.Report this figure

Balance sheet

Cash and equivalents$1.25bn, Q1 FY2026
Long-term debt$311.7m, Q1 FY2024
Shareholders' equity$4.23bn, Q1 FY2026
Roivant Sciences Ltd., balance sheet, quarterly
Line itemUnitQ2 FY20232023-09-30Q3 FY20232023-12-31FY20232024-03-31Q1 FY20242024-06-30Q2 FY20242024-09-30Q3 FY20242024-12-31FY20242025-03-31Q1 FY20252025-06-30Q2 FY20252025-09-30Q3 FY20252025-12-31FY20252026-03-31Q1 FY20262026-06-30
Cash and equivalents$m1,408Cash and equivalents, Q2 FY2023, at 2023-09-30$1.41bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-13, accession 0001140361-23-052721.Report this figure6,671Cash and equivalents, Q3 FY2023, at 2023-12-31$6.67bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-02-13, accession 0001140361-24-007260.Report this figure6,495Cash and equivalents, FY2023, at 2024-03-31$6.49bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-05-29, accession 0001140361-25-020715.Report this figure5,679Cash and equivalents, Q1 FY2024, at 2024-06-30$5.68bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-09, accession 0001140361-24-036642.Report this figure1,959Cash and equivalents, Q2 FY2024, at 2024-09-30$1.96bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-12, accession 0001140361-24-046019.Report this figure1,991Cash and equivalents, Q3 FY2024, at 2024-12-31$1.99bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-02-10, accession 0001140361-25-003661.Report this figure2,715Cash and equivalents, FY2024, at 2025-03-31$2.72bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-05-20, accession 0001635088-26-000061.Report this figure1,238Cash and equivalents, Q1 FY2025, at 2025-06-30$1.24bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-11, accession 0001140361-25-030001.Report this figure1,237Cash and equivalents, Q2 FY2025, at 2025-09-30$1.24bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-10, accession 0001635088-25-000016.Report this figure1,478Cash and equivalents, Q3 FY2025, at 2025-12-31$1.48bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-02-06, accession 0001635088-26-000011.Report this figure1,419Cash and equivalents, FY2025, at 2026-03-31$1.42bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001635088-26-000090.Report this figure1,248Cash and equivalents, Q1 FY2026, at 2026-06-30$1.25bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001635088-26-000090.Report this figure
Current assets$m1,552Current assets, Q2 FY2023, at 2023-09-30$1.55bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-13, accession 0001140361-23-052721.Report this figure6,807Current assets, Q3 FY2023, at 2023-12-31$6.81bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-02-13, accession 0001140361-24-007260.Report this figure6,732Current assets, FY2023, at 2024-03-31$6.73bn. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-05-29, accession 0001140361-25-020715.Report this figure6,001Current assets, Q1 FY2024, at 2024-06-30$6.00bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-09, accession 0001140361-24-036642.Report this figure5,801Current assets, Q2 FY2024, at 2024-09-30$5.80bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-12, accession 0001140361-24-046019.Report this figure5,364Current assets, Q3 FY2024, at 2024-12-31$5.36bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-02-10, accession 0001140361-25-003661.Report this figure5,000Current assets, FY2024, at 2025-03-31$5.00bn. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-05-20, accession 0001635088-26-000061.Report this figure4,616Current assets, Q1 FY2025, at 2025-06-30$4.62bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-11, accession 0001140361-25-030001.Report this figure4,512Current assets, Q2 FY2025, at 2025-09-30$4.51bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-10, accession 0001635088-25-000016.Report this figure4,660Current assets, Q3 FY2025, at 2025-12-31$4.66bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-02-06, accession 0001635088-26-000011.Report this figure5,167Current assets, FY2025, at 2026-03-31$5.17bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001635088-26-000090.Report this figure4,742Current assets, Q1 FY2026, at 2026-06-30$4.74bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001635088-26-000090.Report this figure
Total assets$m2,066Total assets, Q2 FY2023, at 2023-09-30$2.07bn. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-13, accession 0001140361-23-052721.Report this figure7,313Total assets, Q3 FY2023, at 2023-12-31$7.31bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-02-13, accession 0001140361-24-007260.Report this figure7,222Total assets, FY2023, at 2024-03-31$7.22bn. XBRL concept us-gaap:Assets. 10-K filed 2025-05-29, accession 0001140361-25-020715.Report this figure6,496Total assets, Q1 FY2024, at 2024-06-30$6.50bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-09, accession 0001140361-24-036642.Report this figure6,206Total assets, Q2 FY2024, at 2024-09-30$6.21bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-12, accession 0001140361-24-046019.Report this figure5,792Total assets, Q3 FY2024, at 2024-12-31$5.79bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-02-10, accession 0001140361-25-003661.Report this figure5,437Total assets, FY2024, at 2025-03-31$5.44bn. XBRL concept us-gaap:Assets. 10-K filed 2026-05-20, accession 0001635088-26-000061.Report this figure5,033Total assets, Q1 FY2025, at 2025-06-30$5.03bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-11, accession 0001140361-25-030001.Report this figure5,063Total assets, Q2 FY2025, at 2025-09-30$5.06bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-10, accession 0001635088-25-000016.Report this figure5,225Total assets, Q3 FY2025, at 2025-12-31$5.23bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-02-06, accession 0001635088-26-000011.Report this figure5,709Total assets, FY2025, at 2026-03-31$5.71bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001635088-26-000090.Report this figure5,306Total assets, Q1 FY2026, at 2026-06-30$5.31bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001635088-26-000090.Report this figure
Current liabilities$m266Current liabilities, Q2 FY2023, at 2023-09-30$265.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-13, accession 0001140361-23-052721.Report this figure245Current liabilities, Q3 FY2023, at 2023-12-31$244.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-02-13, accession 0001140361-24-007260.Report this figure267Current liabilities, FY2023, at 2024-03-31$266.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-05-29, accession 0001140361-25-020715.Report this figure215Current liabilities, Q1 FY2024, at 2024-06-30$215.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-09, accession 0001140361-24-036642.Report this figure556Current liabilities, Q2 FY2024, at 2024-09-30$556.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-12, accession 0001140361-24-046019.Report this figure141Current liabilities, Q3 FY2024, at 2024-12-31$141.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-02-10, accession 0001140361-25-003661.Report this figure149Current liabilities, FY2024, at 2025-03-31$149.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-05-20, accession 0001635088-26-000061.Report this figure114Current liabilities, Q1 FY2025, at 2025-06-30$113.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-11, accession 0001140361-25-030001.Report this figure134Current liabilities, Q2 FY2025, at 2025-09-30$133.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-10, accession 0001635088-25-000016.Report this figure152Current liabilities, Q3 FY2025, at 2025-12-31$152.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-02-06, accession 0001635088-26-000011.Report this figure281Current liabilities, FY2025, at 2026-03-31$281.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001635088-26-000090.Report this figure284Current liabilities, Q1 FY2026, at 2026-06-30$283.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001635088-26-000090.Report this figure
Total liabilities$m740Total liabilities, Q2 FY2023, at 2023-09-30$739.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-13, accession 0001140361-23-052721.Report this figure728Total liabilities, Q3 FY2023, at 2023-12-31$728.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-02-13, accession 0001140361-24-007260.Report this figure774Total liabilities, FY2023, at 2024-03-31$774.0m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-05-29, accession 0001140361-25-020715.Report this figure601Total liabilities, Q1 FY2024, at 2024-06-30$601.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-09, accession 0001140361-24-036642.Report this figure626Total liabilities, Q2 FY2024, at 2024-09-30$626.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-12, accession 0001140361-24-046019.Report this figure256Total liabilities, Q3 FY2024, at 2024-12-31$256.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-02-10, accession 0001140361-25-003661.Report this figure250Total liabilities, FY2024, at 2025-03-31$249.7m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-05-20, accession 0001635088-26-000061.Report this figure217Total liabilities, Q1 FY2025, at 2025-06-30$216.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-11, accession 0001140361-25-030001.Report this figure257Total liabilities, Q2 FY2025, at 2025-09-30$257.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-10, accession 0001635088-25-000016.Report this figure251Total liabilities, Q3 FY2025, at 2025-12-31$251.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-02-06, accession 0001635088-26-000011.Report this figure416Total liabilities, FY2025, at 2026-03-31$416.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001635088-26-000090.Report this figure385Total liabilities, Q1 FY2026, at 2026-06-30$384.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001635088-26-000090.Report this figure
Long-term debt$m389Long-term debt, Q2 FY2023, at 2023-09-30$389.4m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2023-11-13, accession 0001140361-23-052721.Report this figure403Long-term debt, Q3 FY2023, at 2023-12-31$403.3m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-02-13, accession 0001140361-24-007260.Report this figure431Long-term debt, FY2023, at 2024-03-31$430.6m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-08-09, accession 0001140361-24-036642.Report this figure312Long-term debt, Q1 FY2024, at 2024-06-30$311.7m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-08-09, accession 0001140361-24-036642.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Current portion of debt$m49.0Current portion of debt, Q2 FY2023, at 2023-09-30$49.0m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2023-11-13, accession 0001140361-23-052721.Report this figure45.7Current portion of debt, Q3 FY2023, at 2023-12-31$45.7m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-02-13, accession 0001140361-24-007260.Report this figure12.0Current portion of debt, FY2023, at 2024-03-31$12.0m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-08-09, accession 0001140361-24-036642.Report this figure12.0Current portion of debt, Q1 FY2024, at 2024-06-30$12.0m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-08-09, accession 0001140361-24-036642.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Short-term borrowings$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m949Shareholders' equity, Q2 FY2023, at 2023-09-30$948.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2023-11-13, accession 0001140361-23-052721.Report this figure6,090Shareholders' equity, Q3 FY2023, at 2023-12-31$6.09bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-02-13, accession 0001140361-24-007260.Report this figure5,969Shareholders' equity, FY2023, at 2024-03-31$5.97bn. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2025-05-29, accession 0001140361-25-020715.Report this figure5,435Shareholders' equity, Q1 FY2024, at 2024-06-30$5.44bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-08-09, accession 0001140361-24-036642.Report this figure5,153Shareholders' equity, Q2 FY2024, at 2024-09-30$5.15bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-12, accession 0001140361-24-046019.Report this figure5,189Shareholders' equity, Q3 FY2024, at 2024-12-31$5.19bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-02-10, accession 0001140361-25-003661.Report this figure4,688Shareholders' equity, FY2024, at 2025-03-31$4.69bn. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-05-20, accession 0001635088-26-000061.Report this figure4,346Shareholders' equity, Q1 FY2025, at 2025-06-30$4.35bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-11, accession 0001140361-25-030001.Report this figure4,362Shareholders' equity, Q2 FY2025, at 2025-09-30$4.36bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001635088-25-000016.Report this figure4,269Shareholders' equity, Q3 FY2025, at 2025-12-31$4.27bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-02-06, accession 0001635088-26-000011.Report this figure4,527Shareholders' equity, FY2025, at 2026-03-31$4.53bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001635088-26-000090.Report this figure4,231Shareholders' equity, Q1 FY2026, at 2026-06-30$4.23bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001635088-26-000090.Report this figure

Cash flow

Operating cash flow−$270.5m, Q1 FY2026
Capital expenditure$419.0k, Q1 FY2026
Share repurchases$206.7m, Q1 FY2026
Roivant Sciences Ltd., cash flow, quarterly
Line itemUnitQ2 FY20232023-09-30Q3 FY20232023-12-31Q4 FY20232024-03-31Q1 FY20242024-06-30Q2 FY20242024-09-30Q3 FY20242024-12-31Q4 FY20242025-03-31Q1 FY20252025-06-30Q2 FY20252025-09-30Q3 FY20252025-12-31Q4 FY20252026-03-31Q1 FY20262026-06-30
Operating cash flow$m(196)Operating cash flow, Q2 FY2023, three months to 2023-09-30−$196.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-12, accession 0001140361-24-046019. Derived: 6-month figure less the 3-month figure.Report this figure(210)Operating cash flow, Q3 FY2023, three months to 2023-12-31−$210.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-02-10, accession 0001140361-25-003661. Derived: 9-month figure less the 6-month figure.Report this figure(108)Operating cash flow, Q4 FY2023, three months to 2024-03-31−$108.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-05-20, accession 0001635088-26-000061. Derived: 12-month figure less the 9-month figure.Report this figure(193)Operating cash flow, Q1 FY2024, three months to 2024-06-30−$192.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-11, accession 0001140361-25-030001.Report this figure(267)Operating cash flow, Q2 FY2024, three months to 2024-09-30−$266.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-10, accession 0001635088-25-000016. Derived: 6-month figure less the 3-month figure.Report this figure(207)Operating cash flow, Q3 FY2024, three months to 2024-12-31−$207.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-02-06, accession 0001635088-26-000011. Derived: 9-month figure less the 6-month figure.Report this figure(173)Operating cash flow, Q4 FY2024, three months to 2025-03-31−$172.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-05-20, accession 0001635088-26-000061. Derived: 12-month figure less the 9-month figure.Report this figure(204)Operating cash flow, Q1 FY2025, three months to 2025-06-30−$204.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001635088-26-000090.Report this figure(186)Operating cash flow, Q2 FY2025, three months to 2025-09-30−$185.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-10, accession 0001635088-25-000016. Derived: 6-month figure less the 3-month figure.Report this figure(196)Operating cash flow, Q3 FY2025, three months to 2025-12-31−$196.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-02-06, accession 0001635088-26-000011. Derived: 9-month figure less the 6-month figure.Report this figure(164)Operating cash flow, Q4 FY2025, three months to 2026-03-31−$163.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-05-20, accession 0001635088-26-000061. Derived: 12-month figure less the 9-month figure.Report this figure(271)Operating cash flow, Q1 FY2026, three months to 2026-06-30−$270.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001635088-26-000090.Report this figure
Capital expenditure$m0.3Capital expenditure, Q2 FY2023, three months to 2023-09-30$275.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-12, accession 0001140361-24-046019. Derived: 6-month figure less the 3-month figure.Report this figure0.4Capital expenditure, Q3 FY2023, three months to 2023-12-31$355.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-02-10, accession 0001140361-25-003661. Derived: 9-month figure less the 6-month figure.Report this figure0.3Capital expenditure, Q4 FY2023, three months to 2024-03-31$349.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-05-20, accession 0001635088-26-000061. Derived: 12-month figure less the 9-month figure.Report this figure1.0Capital expenditure, Q1 FY2024, three months to 2024-06-30$965.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-11, accession 0001140361-25-030001.Report this figure1.0Capital expenditure, Q2 FY2024, three months to 2024-09-30$996.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-10, accession 0001635088-25-000016. Derived: 6-month figure less the 3-month figure.Report this figure1.8Capital expenditure, Q3 FY2024, three months to 2024-12-31$1.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-02-06, accession 0001635088-26-000011. Derived: 9-month figure less the 6-month figure.Report this figure0.8Capital expenditure, Q4 FY2024, three months to 2025-03-31$811.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-05-20, accession 0001635088-26-000061. Derived: 12-month figure less the 9-month figure.Report this figure4.0Capital expenditure, Q1 FY2025, three months to 2025-06-30$4.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001635088-26-000090.Report this figure7.8Capital expenditure, Q2 FY2025, three months to 2025-09-30$7.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-10, accession 0001635088-25-000016. Derived: 6-month figure less the 3-month figure.Report this figure(4.9)Capital expenditure, Q3 FY2025, three months to 2025-12-31−$4.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-02-06, accession 0001635088-26-000011. Derived: 9-month figure less the 6-month figure.Report this figure1.3Capital expenditure, Q4 FY2025, three months to 2026-03-31$1.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-05-20, accession 0001635088-26-000061. Derived: 12-month figure less the 9-month figure.Report this figure0.4Capital expenditure, Q1 FY2026, three months to 2026-06-30$419.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001635088-26-000090.Report this figure
Share repurchases$m0.0Share repurchases, Q2 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2024-11-12, accession 0001140361-24-046019. Derived: 6-month figure less the 3-month figure.Report this figure0.0Share repurchases, Q3 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-02-10, accession 0001140361-25-003661. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2023, three months to 2024-03-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2025-05-29, accession 0001140361-25-020715. Derived: 12-month figure less the 9-month figure.Report this figure648Share repurchases, Q1 FY2024, three months to 2024-06-30$648.4m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-08-11, accession 0001140361-25-030001.Report this figure106Share repurchases, Q2 FY2024, three months to 2024-09-30$106.1m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-11-10, accession 0001635088-25-000016. Derived: 6-month figure less the 3-month figure.Report this figure243Share repurchases, Q3 FY2024, three months to 2024-12-31$243.3m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-02-06, accession 0001635088-26-000011. Derived: 9-month figure less the 6-month figure.Report this figure295Share repurchases, Q4 FY2024, three months to 2025-03-31$295.4m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2025-05-29, accession 0001140361-25-020715. Derived: 12-month figure less the 9-month figure.Report this figure208Share repurchases, Q1 FY2025, three months to 2025-06-30$208.3m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-08-06, accession 0001635088-26-000090.Report this figure0.0Share repurchases, Q2 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-11-10, accession 0001635088-25-000016. Derived: 6-month figure less the 3-month figure.Report this figure0.0Share repurchases, Q3 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-02-06, accession 0001635088-26-000011. Derived: 9-month figure less the 6-month figure.Report this figurenot reported207Share repurchases, Q1 FY2026, three months to 2026-06-30$206.7m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-08-06, accession 0001635088-26-000090.Report this figure

Shares

Diluted shares (weighted)720.78m, Q1 FY2026
Roivant Sciences Ltd., shares, quarterly
Line itemUnitQ2 FY20222022-09-30Q3 FY20222022-12-31Q1 FY20232023-06-30Q2 FY20232023-09-30Q3 FY20232023-12-31Q1 FY20242024-06-30Q2 FY20242024-09-30Q3 FY20242024-12-31Q1 FY20252025-06-30Q2 FY20252025-09-30Q3 FY20252025-12-31Q1 FY20262026-06-30
Diluted shares (weighted)m shares700Diluted shares (weighted), Q2 FY2022, three months to 2022-09-30699,888,061 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-13, accession 0001140361-23-052721.Report this figure713Diluted shares (weighted), Q3 FY2022, three months to 2022-12-31713,319,399 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-02-13, accession 0001140361-24-007260.Report this figure759Diluted shares (weighted), Q1 FY2023, three months to 2023-06-30759,273,550 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-09, accession 0001140361-24-036642.Report this figure770Diluted shares (weighted), Q2 FY2023, three months to 2023-09-30770,227,849 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-12, accession 0001140361-24-046019.Report this figure844Diluted shares (weighted), Q3 FY2023, three months to 2023-12-31844,461,685 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-02-10, accession 0001140361-25-003661.Report this figure782Diluted shares (weighted), Q1 FY2024, three months to 2024-06-30781,627,601 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-11, accession 0001140361-25-030001.Report this figure735Diluted shares (weighted), Q2 FY2024, three months to 2024-09-30735,470,796 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-10, accession 0001635088-25-000016.Report this figure723Diluted shares (weighted), Q3 FY2024, three months to 2024-12-31722,716,168 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-02-06, accession 0001635088-26-000011.Report this figure680Diluted shares (weighted), Q1 FY2025, three months to 2025-06-30680,286,922 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001635088-26-000090.Report this figure681Diluted shares (weighted), Q2 FY2025, three months to 2025-09-30680,947,866 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-10, accession 0001635088-25-000016.Report this figure697Diluted shares (weighted), Q3 FY2025, three months to 2025-12-31696,859,682 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-02-06, accession 0001635088-26-000011.Report this figure721Diluted shares (weighted), Q1 FY2026, three months to 2026-06-30720,776,739 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001635088-26-000090.Report this figure

Shares outstanding: 722.32mShares outstanding, period not labelled, at 2026-07-31722,323,015 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-06, accession 0001635088-26-000090.Report this figure at Jul 31, 2026, from the cover of the 10-Q filed Aug 6, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. Listed shows no prices and gives no investment advice.